Dyne Therapeutics, Inc. Contracts & Agreements
47 Contracts & Agreements
- Business Finance (9 contracts)
- Business Operations (1)
- Human Resources (20)
- Intellectual Property (1)
- Real Estate (5)
- Uncategorized (11)
- Offer letter, dated as of July 23, 2024, by and between the registrant and Douglas Kerr (Filed With SEC on November 12, 2024)
- Consulting Agreement, dated as of August 30, 2024, by and between the registrant and Jonathan McNeill (Filed With SEC on November 12, 2024)
- Consulting Agreement, dated as of August 31, 2024, by and between the registrant and Susanna High (Filed With SEC on November 12, 2024)
- Underwriting Agreement, dated May 21, 2024, by and among the Company and Morgan Stanley & Co. LLC, Jefferies LLC, Stifel, Nicolaus & Company, Incorporated and Guggenheim... (Filed With SEC on May 22, 2024)
- Form of Nonstatuory Stock Option Agreement under 2024 Inducement Stock Incentive Plan (Filed With SEC on May 2, 2024)
- Form of Restricted Stock Unit Agreement under 2024 Inducement Stock Incentive Plan (Filed With SEC on May 2, 2024)
- Offer Letter, dated March 21, 2024, between the Company and John Cox (Filed With SEC on March 25, 2024)
- Separation Agreement, dated March 25, 2024, between the Company and Joshua Brumm (Filed With SEC on March 25, 2024)
- Consulting Agreement, dated March 25, 2024, between the Company and Joshua Brumm (Filed With SEC on March 25, 2024)
- Dyne Therapeutics Inc. 2024 Inducement Equity Incentive Plan (Filed With SEC on March 25, 2024)
- Underwriting Agreement, dated January 4, 2024, by and among the Company and Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Jefferies LLC, as representatives of the... (Filed With SEC on January 5, 2024)
- Amended and Restated Executive Severance and Change in Control Benefits Plan (Filed With SEC on November 3, 2022)
- DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 (Filed With SEC on March 10, 2022)
- Lease by and between Dyne Therapeutics, Inc. and BP3-BOS1 1560 Trapelo Road LLC, dated as of December 4, 2020, as amended (Filed With SEC on August 5, 2021)
- Severance agreement between Dyne Therapeutics, Inc. and Romesh Subramanian dated as of June 2, 2021 (Filed With SEC on August 5, 2021)
- Lease by and between Dyne Therapeutics, Inc. and BP3-BOS1 1560 Trapelo Road LLC, dated as of December 4, 2020, as amended (Filed With SEC on May 6, 2021)
- Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 4, 2021)
- Offer letter, dated as of December 17, 2020, by and between the registrant and Wildon Farwell (Filed With SEC on March 4, 2021)
- Form of Underwriting Agreement (Filed With SEC on January 19, 2021)
- Lease, by and between the registrant and BP3-BOS1 1560 Trapelo Road LLC, dated as of December 4, 2020, as amended (Filed With SEC on January 19, 2021)
- Lease, by and between Dyne Therapeutics, Inc. and BP3-BOS1 1560 Trapelo Road LLC, dated as of December 4, 2020 (Filed With SEC on December 9, 2020)
- Form of Underwriting Agreement (Filed With SEC on September 10, 2020)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on September 10, 2020)
- 2018 Stock Incentive Plan, as amended (Filed With SEC on September 10, 2020)
- 2020 Stock Incentive Plan (Filed With SEC on September 10, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on September 10, 2020)
- Amended and Restated Investors Rights Agreement dated as of August 7, 2020 by and among the registrant and the other parties thereto (Filed With SEC on August 25, 2020)
- 2018 Stock Incentive Plan (Filed With SEC on August 25, 2020)
- Form of Stock Option Agreement under 2018 Stock Incentive Plan (Filed With SEC on August 25, 2020)
- Form of Restricted Stock Agreement under 2018 Stock Incentive Plan (Filed With SEC on August 25, 2020)
- 2020 Stock Incentive Plan (Filed With SEC on August 25, 2020)
- Form of Stock Option Agreement under 2020 Stock Incentive Plan (Filed With SEC on August 25, 2020)
- Form of Restricted Stock Agreement under 2020 Stock Incentive Plan (Filed With SEC on August 25, 2020)
- Form of Restricted Stock Unit Agreement under 2020 Stock Incentive Plan (Filed With SEC on August 25, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on August 25, 2020)
- Sublease Agreement, dated May 20, 2019, by and between Arrakis Therapeutics, Inc., as sublandlord, and the registrant, as subtenant (Filed With SEC on August 25, 2020)
- Form of Indemnification Agreement between the registrant and each of its executive officers and directors (Filed With SEC on August 25, 2020)
- License Agreement, dated as of April 27, 2020, by and between the registrant and the University of Mons (Filed With SEC on August 25, 2020)
- Loan and Security Agreement, dated as of February 20, 2020, by and between the registrant and Pacific Western Bank (Filed With SEC on August 25, 2020)
- Offer letter, dated as of September 19, 2019, by and between the registrant and Joshua Brumm (Filed With SEC on August 25, 2020)
- Offer letter, dated as of March 21, 2018, by and between the registrant and Romesh Subramanian (Filed With SEC on August 25, 2020)
- Employment side letter, dated as of November 29, 2018, by and between the registrant and Romesh Subramanian (Filed With SEC on August 25, 2020)
- Offer letter, dated as of December 21, 2018, by and between the registrant and Jonathan McNeill (Filed With SEC on August 25, 2020)
- Offer letter, dated as of December 12, 2019, by and between the registrant and Oxana Beskrovnaya (Filed With SEC on August 25, 2020)
- Offer letter, dated as of November 8, 2019, by and between the registrant and Richard Scalzo (Filed With SEC on August 25, 2020)
- Offer letter, dated as of July 24, 2020, by and between the registrant and Susanna High (Filed With SEC on August 25, 2020)
- Executive Severance and Change in Control Benefits Plan (Filed With SEC on August 25, 2020)
